Cargando…

Antismoking agents do not contribute synergistically to semaglutide’s ability to reduce alcohol intake in rats

Preclinical studies have identified glucagon-like peptide-1 receptor (GLP-1R) agonists, and the antismoking agents varenicline and bupropion as tentative agents for treatment of alcohol use disorder (AUD). Combining different medications is a recent approach that has gained attention regarding heter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aranäs, Cajsa, Blid Sköldheden, Sebastian, Jerlhag, Elisabet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500129/ https://www.ncbi.nlm.nih.gov/pubmed/37719854 http://dx.doi.org/10.3389/fphar.2023.1180512

Ejemplares similares

Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats
por: Aranäs, Cajsa, et al.
Publicado: (2023)

Effects of sub-chronic amylin receptor activation on alcohol-induced locomotor stimulation and monoamine levels in mice
por: Kalafateli, Aimilia Lydia, et al.
Publicado: (2020)

Salmon Calcitonin Attenuates Some Behavioural Responses to Nicotine in Male Mice
por: Aranäs, Cajsa, et al.
Publicado: (2021)

The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies
por: Jerlhag, Elisabet
Publicado: (2023)

Neurophysiological Profile of Antismoking Campaigns
por: Modica, Enrica, et al.
Publicado: (2018)

Peripherally Circulating Ghrelin Does Not Mediate Alcohol‐Induced Reward and Alcohol Intake in Rodents
por: Jerlhag, Elisabet, et al.
Publicado: (2014)

Brain region‐specific neuromedin U signalling regulates alcohol‐related behaviours and food intake in rodents
por: Vallöf, Daniel, et al.
Publicado: (2019)

Central administration of the anorexigenic peptide neuromedin U decreases alcohol intake and attenuates alcohol‐induced reward in rodents
por: Vallöf, Daniel, et al.
Publicado: (2016)

Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice
por: Chen, Xiaoyi, et al.
Publicado: (2023)

Animal studies reveal that the ghrelin pathway regulates alcohol-mediated responses
por: Jerlhag, Elisabet
Publicado: (2023)

Antismoking Messages and Intention to Quit — 17 Countries, 2008–2011
por: Caixeta, Roberta B., et al.
Publicado: (2013)

Using Serious Games for Antismoking Health Campaigns: Experimental Study
por: Kim, Jihyun, et al.
Publicado: (2020)

Efficacy and Safety of Subcutaneous and Oral Semaglutide Administration in Patients With Type 2 Diabetes: A Meta-Analysis
por: Zhong, Ping, et al.
Publicado: (2021)

Exploring the Appropriate Price of Semaglutide for Type 2 Diabetes Patients Based on Cost-Utility Analysis in China
por: Hu, Shanshan, et al.
Publicado: (2021)

Correction: Using Serious Games for Antismoking Health Campaigns: Experimental Study
por: Kim, Jihyun, et al.
Publicado: (2021)

Role of glutamate transporter 1 in the attenuation of alcohol intake
por: Sari, Youssef
Publicado: (2014)

Biomimetic ZIF8 Nanosystem With Tumor Hypoxia Relief Ability to Enhance Chemo-Photothermal Synergistic Therapy
por: Zhao, Ziming, et al.
Publicado: (2022)

A Review of Resveratrol as a Potent Chemoprotective and Synergistic Agent in Cancer Chemotherapy
por: Xiao, Qicai, et al.
Publicado: (2019)

A Smoking Survey of College Students in India: Implications for Designing an Antismoking Policy
por: Gavarasana, Satyanarayana, et al.
Publicado: (1991)

Neurophysiological Measures of the Perception of Antismoking Public Service Announcements Among Young Population
por: Cartocci, Giulia, et al.
Publicado: (2018)

Exposure to Court-Ordered Tobacco Industry Antismoking Advertisements Among US Adults
por: Chido-Amajuoyi, Onyema Greg, et al.
Publicado: (2019)

Antismoking Campaigns' Perception and Gender Differences: A Comparison among EEG Indices
por: Cartocci, Giulia, et al.
Publicado: (2019)

Activation of amylin receptors attenuates alcohol‐mediated behaviours in rodents
por: Kalafateli, Aimilia Lydia, et al.
Publicado: (2018)

Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity
por: Quddos, Fatima, et al.
Publicado: (2023)

Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats
por: Vallöf, Daniel, et al.
Publicado: (2020)

Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Shi, Fang-Hong, et al.
Publicado: (2018)

Synergistic effects of natural products in combination with anticancer agents in prostate cancer: A scoping review
por: Cheon, Chunhoo, et al.
Publicado: (2022)

Antismoking Media Campaign and Smoking Cessation Outcomes, New York State, 2003-2009
por: Davis, Kevin C., et al.
Publicado: (2012)

Qualitative study of Singaporean youths’ perception of antismoking campaigns: what works and what does not
por: Shahwan, Shazana, et al.
Publicado: (2016)

Web-Based Antismoking Advertising to Promote Smoking Cessation: A Randomized Controlled Trial
por: Yom-Tov, Elad, et al.
Publicado: (2016)

Ghrelin Receptor (GHS-R1A) Antagonism Suppresses Both Alcohol Consumption and the Alcohol Deprivation Effect in Rats following Long-Term Voluntary Alcohol Consumption
por: Suchankova, Petra, et al.
Publicado: (2013)

Cost-Utility Analysis of Once-Weekly Semaglutide, Dulaglutide, and Exenatide for Type 2 Diabetes Patients Receiving Metformin-Based Background Therapy in China
por: Hu, Shanshan, et al.
Publicado: (2022)

Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials
por: Gao, Xueqin, et al.
Publicado: (2022)

Insight into the role of the gut-brain axis in alcohol-related responses: Emphasis on GLP-1, amylin, and ghrelin
por: Tufvesson-Alm, Maximilian, et al.
Publicado: (2023)

In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii
por: Bae, Seongman, et al.
Publicado: (2016)

Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar rats
por: Momeni, Shima, et al.
Publicado: (2015)

Efficacy and safety of semaglutide in non-alcoholic fatty liver disease
por: Zhu, Kai, et al.
Publicado: (2023)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

Chymase Inhibitor as a Novel Therapeutic Agent for Non-alcoholic Steatohepatitis
por: Takai, Shinji, et al.
Publicado: (2018)

Synergistic Effect of Pleuromutilins with Other Antimicrobial Agents against Staphylococcus aureus In Vitro and in an Experimental Galleria mellonella Model
por: Dong, Chun-Liu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f0hqipk4h9fq8uvbtc74fcve3i